Alternative Energy Cybin receives FDA approval for new in-human clinical trial Patient enlistment for new study to treat Major Depressive Disorder set to begin promptly Rowan DunneJune 28, 2022
Psychedelics Nirvana Life Sciences boasts new patent for innovative psychedelic compound Company isolates 4-PO-Psilocin into biologically active salt with 99% purity ratio Rowan DunneJune 23, 2022
Canada Psilocybin and craft cannabis farmers to gather in B.C. Meeting for Vancouver Island growers and community leaders to be held on June 16. Rowan DunneJune 9, 2022
Medical and Pharmaceutical Delic Labs granted permission to study psychedelics including LSD, MDMA The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds Ryan GarnerApril 15, 2022
News Psilocybin therapy for major depression can relieve symptoms for a year: study The long-term benefits contrast with the more temporary effects of conventional antidepressants Natalia Buendia CalvilloFebruary 18, 2022
Canada Canadian health professionals are limited to clinical trials to access psilocybin. Experts say that’s unethical Health Canada's guidance on how to access illicit substances for medical purposes has been a moving target over the past year Natalia Buendia CalvilloFebruary 16, 2022
Canada Canadian advocates denounce ‘flawed’ system for legal psilocybin access It appeared Health Canada was increasing access to the substance, but recent events suggest otherwise Natalia Buendia CalvilloFebruary 3, 2022
Business Numinus uplists to OTCQX Best Market Stock will start trading at market open Thursday under the symbol NUMIF Natalia Buendia CalvilloJanuary 26, 2022
International UK Prime Minister to consider reducing legal barriers to psilocybin research Conservative MP and drug policy reform chair Crispin Blunt suggests reclassifying the substance to a less severe category of the country's drug law Natalia Buendia CalvilloOctober 25, 2021